2021 Online, In the cloud

II-74 Julie Dudasova
A method to estimate probability of disease and vaccine efficacy from clinical trial immunogenicity data
II-75 Undine Falkenhagen
Reducing QSP models to derive mechanism-based PD models: warfarin-INR as an example
II-76 Sergey Gavrilov
Survival Model-based Meta-Analysis Framework for the Indirect Comparison of Anti-Cancer Therapy Efficacy
II-77 Mohamed Gewily
Model Averaging Across Parametric and Non-Parametric Methods as an Aid for Clinical Decision Making
II-78 Elham Haem
Comparison of the power and type-1 error of composite score models for drug effect detection in clinical trials
II-79 Vincent Hurez
Development of a systemic lupus erythematosus (SLE) QSP model linking systemic biomarkers to cutaneous clinical score (CLASI) outcomes.
II-80 Mutaz Jaber
Investigating Components of Residual Unexplained Variability in Nonlinear Mixed-Effect Modeling
II-81 Daniel Kaschek
Crossing borders from mechanistic QSP to clinical population modeling
II-82 Aurélie Lereclus
Lithium pharmacometrics: review of population pharmacokinetics models, external evaluation using non compartmental literature data and model’s updating based on straightforward integration of glomerular filtration rate.
II-83 Klaus Lindauer
Evaluation of random forest as an approach for covariate selection
II-84 Dan Lu
Machine and deep learning approaches for disease progression modeling: illustration with geographic atrophy
II-85 Moustafa M. A. Ibrahim
Enhancing Efficiency and Decision Quality in Parkinson’s Disease Drug Trials for LRRK2 Programs Using Item Response Modelling
II-86 Rikard Nordgren
Pharmpy and assemblerr - Two novel tools to simplify the model building process in NONMEM
II-87 Raman Sharma
A probabilistic approach to calculating probability of achieving target pharmacological effect levels for a novel orally administered antibacterial chemotherapeutic
II-89 Gustaf Wellhagen
Item Response Theory-Informed Total Score Analysis
II-90 Xiao Zhu
Positive allosteric modulators - a challenge for development of QSP models